Category: Covidien
MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of 2012.
The medical device industry was full of big stories in 2012, ranging from efforts to bring down the device tax and related layoffs to epic public face-offs between industry leaders.
Covidien releases 5- year results of its ClosureFast Long-Term European Multi-Center Study in treating patients with chronic venous insufficiency.
Covidien (NYSE:COV) unveiled the results of its ClosureFast Long-Term European Multi-Center Study, which evaluated 5-year outcomes of the medical device maker's radiofrequency ablation therapy in patients with chronic venous insufficiency.
Medical devices made a lot of headlines in 2012, and the word "layoffs" was in many of them.
The medical device industry had a lot of big stories during the last year, including tales of recalls, lawsuits and CEO swapping, but the single factor that drove more big headlines than any other was news of layoffs.
Some of the biggest companies in the industry announced significant cuts in 2012, amounting to about 7,000 reported layoffs, by some estimates.
Medical device company Covidien expects to put at least $50 million toward R&D to progress drug-coated balloon technologies its about to acquire from CV Ingenuity.
Massachusetts medical device company Covidien (NYSE:COV) signed a definitive agreement to acquire drug-coated balloon maker CV Ingenuity, planning to put millions toward R&D over the next 2 years.
Publicly traded medical device companies shed about 7,000 jobs in the 2012, representing 1.6% of the industry's U.S. jobs base.
High-ranking medical device makers cut about 7,000 American jobs in 2012, representing about 1.6% of the industry's total U.S. workforce, according to a Reuters report.
Angel Medical Systems raises nearly $28 million for its ischemia monitoring device, designed to give early warning of an incipient heart attack.
Angel Medical Systems said it's closed a funding round worth $28 million for its AngelMed Guardian implant, designed to detect the early heart problems that can lead to heart attacks and alert patients to seek medical care.
The round included existing backers and a new contribution from SOAM Angel Partners, which added principal Dr. Victor Whitman to Angel Medical's board, according to a press release.
GE Healthcare integrates Covidien’s Nellcor SpO2 monitors into its Giraffe and Panda infant warmers, aiming to help clinicians safely monitor and screen infants.
